Search research articles
Contact Us
Filters
Showing results (11-20 of 58) with videos related to
Page
of 6
Sort By:
Canadian Journal of Diabetes
|
April 14, 2018
Chronic Kidney Disease in Diabetes
, Philip McFarlane, David Cherney, et al.
Kidney Medicine
|
August 1, 2020
Tubuloglomerular Feedback in Renal Glucosuria: Mimicking Long-term SGLT-2 Inhibitor Therapy
Hannes Neuwirt, Andrea Burtscher, David Cherney, et al.
European Journal of Internal Medicine
|
April 12, 2023
Tirzepatide decreases systolic and diastolic blood pressure
Sidar Copur, Atalay Demiray, David Cherney, et al.
Journal of Diabetes and Its Complications
|
July 15, 2022
Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines
Elisabeth B Stougaard, Peter Rossing, David Cherney, et al.
Journal of the American Society of Nephrology : JASN
|
September 17, 2025
Authors' Reply: Tirzepatide and Kidney Protection in Obesity: Unanswered Questions
Hiddo J L Heerspink, Petter Bjornstad, David Cherney, et al.
Nature Reviews. Nephrology
|
January 12, 2026
Next-generation therapeutics for diabetic kidney disease
Tae Won Yi, Vikas S Sridhar, Jennifer Scott, et al.
Journal of Market Access & Health Policy
|
August 28, 2024
Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison
David Cherney, Kerstin Folkerts, Paul Mernagh, et al.
Plos One
|
October 31, 2017
The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome
David Cherney, Bruce A Perkins, Yuliya Lytvyn, et al.
Cardiorenal Medicine
|
December 17, 2025
The Role of Inflammation and High-Sensitivity C-reactive Protein in Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease: the FLAME-ASCVD Survey Among Nephrologists
Vlado Perkovic, David Cherney, Edmundo Erazo-Tapia, et al.
Cardiorenal Medicine
|
January 31, 2019
Biomarkers of Inflammation, Fibrosis, and Acute Kidney Injury in Patients with Heart Failure with and without Left Ventricular Assist Device Implantation
Liza Grosman-Rimon, Sarah Genevieve Hui, Danit Freedman, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 58) with videos related to
Sort By:
Page
of 6
Canadian Journal of Diabetes
|
April 14, 2018
Chronic Kidney Disease in Diabetes
, Philip McFarlane, David Cherney, et al.
Kidney Medicine
|
August 1, 2020
Tubuloglomerular Feedback in Renal Glucosuria: Mimicking Long-term SGLT-2 Inhibitor Therapy
Hannes Neuwirt, Andrea Burtscher, David Cherney, et al.
European Journal of Internal Medicine
|
April 12, 2023
Tirzepatide decreases systolic and diastolic blood pressure
Sidar Copur, Atalay Demiray, David Cherney, et al.
Journal of Diabetes and Its Complications
|
July 15, 2022
Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines
Elisabeth B Stougaard, Peter Rossing, David Cherney, et al.
Journal of the American Society of Nephrology : JASN
|
September 17, 2025
Authors' Reply: Tirzepatide and Kidney Protection in Obesity: Unanswered Questions
Hiddo J L Heerspink, Petter Bjornstad, David Cherney, et al.
Nature Reviews. Nephrology
|
January 12, 2026
Next-generation therapeutics for diabetic kidney disease
Tae Won Yi, Vikas S Sridhar, Jennifer Scott, et al.
Journal of Market Access & Health Policy
|
August 28, 2024
Comparative Efficacy of Finerenone versus Canagliflozin in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Matching-Adjusted Indirect Comparison
David Cherney, Kerstin Folkerts, Paul Mernagh, et al.
Plos One
|
October 31, 2017
The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome
David Cherney, Bruce A Perkins, Yuliya Lytvyn, et al.
Cardiorenal Medicine
|
December 17, 2025
The Role of Inflammation and High-Sensitivity C-reactive Protein in Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease: the FLAME-ASCVD Survey Among Nephrologists
Vlado Perkovic, David Cherney, Edmundo Erazo-Tapia, et al.
Cardiorenal Medicine
|
January 31, 2019
Biomarkers of Inflammation, Fibrosis, and Acute Kidney Injury in Patients with Heart Failure with and without Left Ventricular Assist Device Implantation
Liza Grosman-Rimon, Sarah Genevieve Hui, Danit Freedman, et al.
Page
of 6